A meeting of the Board of Directors of Neimeth International Pharmaceuticals Plc. (the Company) is scheduled to hold on Thursday, 27 October 2022, to consider and approve the Company's Unaudited Financial Statements for Quarter 3 ended 30^th September 2022.

In line with the NGX’s Amended Closed Period Rules, the Company commenced a closed period from 1st October 2022 and this will run up to twenty-four (24) hours after the outcome of the meeting and the Unaudited Financial Statements for the period ended 30^th September 2022 is released to the public.

Consequently, Directors and other Insiders of the Company have been duly notified not to deal in the Company’s securities during the closed period.